CYTENA’s Post

🚀 Watch this on-demand expert panel dialog and download the executive summary! 🌟 Learn from industry leaders about the significance of circRNA technology in medicine, key analytical technologies, and the challenges of developing circRNA therapeutics. 📅 Event Highlights: • Expert presentations on therapeutic applications, structural identification, and analytical methods. • In-depth discussion with experts. 👥 Featuring: • Francis Poulin (Sail Biomedicines) • Nikoloas Mellios (Circular Genomics) • Andy Coffey (Agilent) Don’t miss this chance to gain valuable insights! 💡 https://bit.ly/4f9Cbjt #circRNA #Biotechnology #ExpertDiscussion

🚀 Watch this on-demand expert panel dialog and download the executive summary! 🌟 Learn from industry leaders about the significance of circRNA technology in medicine, key analytical technologies, and the challenges of developing circRNA therapeutics. 📅 Event Highlights: • Expert presentations on therapeutic applications, structural identification, and analytical methods. • In-depth discussion with experts. 👥 Featuring: • Francis Poulin (Sail Biomedicines) • Nikoloas Mellios (Circular Genomics) • Andy Coffey (Agilent) Don’t miss this chance to gain valuable insights! 💡 https://bit.ly/4f9Cbjt #circRNA #Biotechnology #ExpertDiscussion

Curious about the groundbreaking advancements in microbiome-based therapeutics? Explore the insights shared by our Chief Scientific Officer, Christopher Weidenmaier, PhD, and Chief Technology Officer, Johannes B. Woehrstein, PhD, as they discuss the challenges and considerations in manufacturing LBPs 🧪 The journey to harnessing the power of the human microbiome is both exhilarating and complex. Discover the remarkable efficacy of complex live biotherapeutic products (LBPs) in modulating the microbiome, evidenced by the recent approvals of Rebyota and VOWST. Read the full article on EPR to uncover the future of microbiome-based treatments: https://bit.ly/4bhMqAw #LBPs #MicrobiomeTherapeutics #BiotechInnovation #ScienceAndTechnology #EPR

Attention all Macrophage Experts! 📢 If you're looking to learn from the past and 𝗽𝗿𝗼𝗽𝗲𝗹 𝘆𝗼𝘂𝗿 𝗺𝗮𝗰𝗿𝗼𝗽𝗵𝗮𝗴𝗲 𝘁𝗵𝗲𝗿𝗮𝗽𝗶𝗲𝘀 𝘁𝗼 𝗰𝗹𝗶𝗻𝗶𝗰, look no further than the 𝟲𝘁𝗵 𝗠𝗮𝗰𝗿𝗼𝗽𝗵𝗮𝗴𝗲-𝗗𝗶𝗿𝗲𝗰𝘁𝗲𝗱 𝗧𝗵𝗲𝗿𝗮𝗽𝗶𝗲𝘀 𝗦𝘂𝗺𝗺𝗶𝘁! 𝗙𝘂𝗹𝗹 𝗔𝗴𝗲𝗻𝗱𝗮 𝗛𝗲𝗿𝗲 ➡️ https://bit.ly/455dOQ7 𝗨𝗻𝗶𝘁𝗶𝗻𝗴 𝟲𝟬+ 𝗯𝗶𝗼𝗽𝗵𝗮𝗿𝗺𝗮 𝗮𝗻𝗱 𝗮𝗰𝗮𝗱𝗲𝗺𝗶𝗮 𝗹𝗲𝗮𝗱𝗲𝗿𝘀 across R&D, discovery, biology, translational science, and clinical development, this is poised to be a must-attend event, deep-diving into the evolving macrophage-therapeutics landscape, exploring other indications, and tackling the most pressing industry challenges.💡 𝗗𝗼𝘄𝗻𝗹𝗼𝗮𝗱 𝘁𝗵𝗲 𝗙𝘂𝗹𝗹 𝗣𝗿𝗼𝗴𝗿𝗮𝗺 ➡️ https://bit.ly/455dOQ7 This is an incredible opportunity to unlock the full potential of your own macrophage therapeutics, with insights from 𝗖𝗮𝗿𝗶𝘀𝗺𝗮 𝗧𝗵𝗲𝗿𝗮𝗽𝗲𝘂𝘁𝗶𝗰𝘀, 𝗘𝗹𝗽𝗶𝘀𝗰𝗶𝗲𝗻𝗰𝗲 𝗕𝗶𝗼𝗽𝗵𝗮𝗿𝗺𝗮𝗰𝗲𝘂𝘁𝗶𝗰𝗮𝗹𝘀, 𝗝𝗼𝗵𝗻 𝗛𝗼𝗽𝗸𝗶𝗻𝘀 𝗦𝗰𝗵𝗼𝗼𝗹 𝗼𝗳 𝗠𝗲𝗱𝗶𝗰𝗶𝗻𝗲, 𝗔𝗟𝗫 𝗢𝗻𝗰𝗼𝗹𝗼𝗴𝘆, 𝗩𝗲𝗿𝘀𝗲𝗮𝘂 𝗧𝗵𝗲𝗿𝗮𝗽𝗲𝘂𝘁𝗶𝗰𝘀, and many more!🔓 Book your seat at https://bit.ly/450Afpr before Friday to 𝘀𝗮𝘃𝗲 𝘂𝗽 𝘁𝗼 $𝟵𝟬𝟬, plus an 𝗮𝗱𝗱𝗶𝘁𝗶𝗼𝗻𝗮𝗹 𝟮𝟬% 𝗱𝗶𝘀𝗰𝗼𝘂𝗻𝘁 when you bring 5 or more colleagues, which will facilitate valuable collaborative learning within your team. #MacrophageDirectedTherapiesSummit

How Do NOX2 and NOX4 Expression in Monocytes and Macrophages Influence Extracellular Vesicles in Signaling and Therapeutics? Join Ankush Prasad, PhD, Palacky University, Czech Republic at #RedoxMedicine2024 where he will present a poster developing this topic. The study that will be presented  examines the roles of NOX2 and NOX4 expression in monocytes and macrophages, focusing on their impact on extracellular vesicles. The findings highlight potential therapeutic applications and the importance of these enzymes in cellular signaling pathways. Join us on June 27-28, 2024 at Fondation Biermans-Lapôtre, Paris! 🔗 Accepted Posters: https://lnkd.in/gWjW7R7G 🌐 Learn More: https://lnkd.in/dkNzFQZU. #RedoxMedicieSociety #RedoxMedicine2024 #biomarkers #redoxbiology #redox #antioxidants #innovation #oxidativestress #RedoxResearch

𝐁𝟑𝐆𝐀𝐋𝐍𝐓𝟐 & 𝐁𝟑𝐆𝐋𝟐 𝐀𝐧𝐭𝐢𝐛𝐨𝐝𝐲 𝐌𝐚𝐫𝐤𝐞𝐭: 𝐆𝐫𝐨𝐰𝐭𝐡 𝐃𝐫𝐢𝐯𝐞𝐫𝐬 𝐚𝐧𝐝 𝐊𝐞𝐲 𝐓𝐫𝐞𝐧𝐝𝐬 The B3GALNT2 & B3GL2 antibody market is expanding due to the increasing demand for targeted therapies and diagnostics in oncology and autoimmune diseases. These antibodies play a crucial role in cellular signaling and glycobiology, making them essential tools in cancer research and disease treatment. The market is driven by advancements in biotechnology, growing research activities, and the need for personalized medicine. 𝐋𝐞𝐚𝐫𝐧 𝐌𝐨𝐫𝐞: https://lnkd.in/dF3u63Kz 𝐓𝐨𝐩 𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬: Thermo Fisher Scientific, Abcam, Cell Signaling Technology (CST), Bio-Techne, Santa Cruz Biotechnology (SCBT), Sigma-Aldrich, GenScript, Boster Biological Technology, Novus Biologicals, a Bio-Techne brand, Eureka Therapeutics, Inc, Enzo Life Sciences, Inc., GeneTex, Inc., OriGene , Cosmo Bio USA, Rockland Immunochemicals, Inc., Cayman Chemical, VWR, part of Avantor, RayBiotech, Miltenyi Biotec, LSBio | LifeSpan BioSciences, Inc., MyBioSource, R&D Systems, Hologic Diagenode, Proteomics International, BioLegend. 𝐇𝐚𝐬𝐡𝐭𝐚𝐠: #B3GALNT2Antibody #B3GL2Antibody #CancerResearch #Biotechnology #PersonalizedMedicine

As part of the Human Cell Atlas Project, scientists have mapped the human endometrium in unprecedented detail, revealing diverse cell types and their changes during the menstrual cycle. This comprehensive map holds promise for developing new therapeutics for conditions like endometriosis. https://lnkd.in/eMteu4Mi

Flow cytometry plays a pivotal role in clinical development by enabling detailed, single-cell analysis to assess immune responses and therapeutic efficacy. In our latest Q&A, Medpace scientists explain how this powerful tool can enhance trials by analyzing thousands of cells simultaneously, supporting CAR-T therapy, and assessing biologic therapies.   Download the article to learn more about the role of flow cytometry in clinical trial #biomarkers: https://lnkd.in/gqwATyH8

Need differentiated cells on your iPSC patient specific lines? Or do you have a unique line that poorly differentiates with your own protocol and you need help? If you face such challenges let Trailhead assist - this is one way where the power of HD-DoE can help. #ipsc #pluripotent #stemcell #drugdiscovery #trailbio #hddoe #cellmanufacturing #biomanufacturing #qbd #designofexperiments